MKI67 and mantle cell lymphoma: Significant differences were not observed in Ki-67 expression and average survival time among groups of different immune phenotypes of classic MCL (group CD5+ cyclin D1+, CD5− and cyclin D1+ and group CD5+ and cyclin D1−) (P>0.05).